(APA) APA - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US03743Q1085
Stock: Natural Gas, Crude Oil, Natural Gas Liquids
Total Rating 60
Risk 66
Buy Signal 0.77
| Risk 5d forecast | |
|---|---|
| Volatility | 44.0% |
| Relative Tail Risk | -6.20% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.29 |
| Alpha | 54.83 |
| Character TTM | |
|---|---|
| Beta | 1.301 |
| Beta Downside | 2.211 |
| Drawdowns 3y | |
|---|---|
| Max DD | 67.45% |
| CAGR/Max DD | 0.07 |
EPS (Earnings per Share)
Revenue
Description: APA APA February 28, 2026
APA Corporation (NASDAQ: APA) is an independent energy firm that explores, develops, and produces natural gas, crude oil, and natural-gas liquids across the United States, Egypt, and the North Sea, with additional exploration in Suriname and project interests in Uruguay and elsewhere. Founded in 1954 and based in Houston, Texas, APA operates within the Oil & Gas Exploration & Production sub-industry.
In its most recent quarter (Q4 2025), APA reported average production of 210 k boe/d, a 8% rise versus the prior year, driven largely by higher output in the Eagle Ford and North Sea assets. Net cash flow reached $1.2 billion, supporting a 2.5% dividend yield and a debt-to-equity ratio of 0.6. The company’s earnings are increasingly tied to natural-gas price dynamics, with U.S. Henry Hub gas trading near $3.10 /MMBtu-up 12% YoY-thanks to growing LNG export demand and constrained pipeline capacity.
For a deeper dive into APA’s valuation metrics and how they compare across the sector, you might explore the analysis on ValueRay.
Headlines to watch out for
- Global crude oil prices dictate exploration and production revenue
- Natural gas demand impacts realized commodity prices
- Geopolitical stability in Egypt affects operational continuity
- Suriname exploration success drives future growth prospects
- Regulatory changes in US environmental policy increase operating costs
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 1.43b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 5.38 > 1.0 |
| NWC/Revenue: -5.04% < 20% (prev 4.61%; Δ -9.66% < -1%) |
| CFO/TA 0.24 > 3% & CFO 4.54b > Net Income 1.43b |
| Net Debt (4.29b) to EBITDA (5.46b): 0.79 < 3 |
| Current Ratio: 0.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (355.0m) vs 12m ago -3.79% < -2% |
| Gross Margin: 38.09% > 18% (prev 0.44%; Δ 3.77k% > 0.5%) |
| Asset Turnover: 46.47% > 50% (prev 50.22%; Δ -3.74% > 0%) |
| Interest Coverage Ratio: 11.52 > 6 (EBITDA TTM 5.46b / Interest Expense TTM 265.0m) |
Altman Z'' 0.75
| A: -0.02 (Total Current Assets 2.12b - Total Current Liabilities 2.57b) / Total Assets 19.00b |
| B: -0.04 (Retained Earnings -721.0m / Total Assets 19.00b) |
| C: 0.16 (EBIT TTM 3.05b / Avg Total Assets 19.19b) |
| D: -0.03 (Book Value of Equity -403.0m / Total Liabilities 11.99b) |
| Altman-Z'' Score: 0.75 = B |
Beneish M -3.29
| DSRI: 0.59 (Receivables 1.06b/1.96b, Revenue 8.92b/9.74b) |
| GMI: 1.16 (GM 38.09% / 44.18%) |
| AQI: 1.26 (AQ_t 0.22 / AQ_t-1 0.17) |
| SGI: 0.92 (Revenue 8.92b / 9.74b) |
| TATA: -0.16 (NI 1.43b - CFO 4.54b) / TA 19.00b) |
| Beneish M-Score: -3.29 (Cap -4..+1) = AA |
What is the price of APA shares?
As of March 13, 2026, the stock is trading at USD 32.97 with a total of 6,375,038 shares traded.
Over the past week, the price has changed by +3.80%, over one month by +24.85%, over three months by +30.85% and over the past year by +79.88%.
Over the past week, the price has changed by +3.80%, over one month by +24.85%, over three months by +30.85% and over the past year by +79.88%.
Is APA a buy, sell or hold?
APA has received a consensus analysts rating of 3.10.
Therefor, it is recommend to hold APA.
- StrongBuy: 4
- Buy: 3
- Hold: 17
- Sell: 2
- StrongSell: 3
What are the forecasts/targets for the APA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 29.2 | -11.4% |
| Analysts Target Price | 29.2 | -11.4% |
APA Fundamental Data Overview March 10, 2026
P/E Trailing = 7.8182
P/E Forward = 14.7275
P/S = 1.3463
P/B = 1.9431
P/EG = 3.6802
Revenue TTM = 8.92b USD
EBIT TTM = 3.05b USD
EBITDA TTM = 5.46b USD
Long Term Debt = 4.28b USD (from longTermDebt, two quarters ago)
Short Term Debt = 310.0m USD (from shortTermDebt, last quarter)
Debt = 4.81b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.29b USD (from netDebt column, last quarter)
Enterprise Value = 15.99b USD (11.69b + Debt 4.81b - CCE 516.0m)
Interest Coverage Ratio = 11.52 (Ebit TTM 3.05b / Interest Expense TTM 265.0m)
EV/FCF = 8.99x (Enterprise Value 15.99b / FCF TTM 1.78b)
FCF Yield = 11.13% (FCF TTM 1.78b / Enterprise Value 15.99b)
FCF Margin = 19.94% (FCF TTM 1.78b / Revenue TTM 8.92b)
Net Margin = 16.08% (Net Income TTM 1.43b / Revenue TTM 8.92b)
Gross Margin = 38.09% ((Revenue TTM 8.92b - Cost of Revenue TTM 5.52b) / Revenue TTM)
Gross Margin QoQ = 39.23% (prev 38.68%)
Tobins Q-Ratio = 0.84 (Enterprise Value 15.99b / Total Assets 19.00b)
Interest Expense / Debt = 1.21% (Interest Expense 58.0m / Debt 4.81b)
Taxrate = 32.31% (158.0m / 489.0m)
NOPAT = 2.07b (EBIT 3.05b * (1 - 32.31%))
Current Ratio = 0.82 (Total Current Assets 2.12b / Total Current Liabilities 2.57b)
Debt / Equity = 0.79 (Debt 4.81b / totalStockholderEquity, last quarter 6.09b)
Debt / EBITDA = 0.79 (Net Debt 4.29b / EBITDA 5.46b)
Debt / FCF = 2.41 (Net Debt 4.29b / FCF TTM 1.78b)
Total Stockholder Equity = 5.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.47% (Net Income 1.43b / Total Assets 19.00b)
RoE = 24.51% (Net Income TTM 1.43b / Total Stockholder Equity 5.85b)
RoCE = 30.14% (EBIT 3.05b / Capital Employed (Equity 5.85b + L.T.Debt 4.28b))
RoIC = 19.54% (NOPAT 2.07b / Invested Capital 10.57b)
WACC = 7.83% (E(11.69b)/V(16.50b) * Re(10.71%) + D(4.81b)/V(16.50b) * Rd(1.21%) * (1-Tc(0.32)))
Discount Rate = 10.71% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 7.53%
[DCF] Terminal Value 75.30% ; FCFF base≈1.38b ; Y1≈1.11b ; Y5≈773.1m
[DCF] Fair Price = 29.38 (EV 14.71b - Net Debt 4.29b = Equity 10.42b / Shares 354.7m; r=7.83% [WACC]; 5y FCF grow -22.85% → 2.90% )
EPS Correlation: -78.36 | EPS CAGR: -18.05% | SUE: 0.86 | # QB: 1
Revenue Correlation: -34.40 | Revenue CAGR: -7.52% | SUE: -1.11 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.49 | Chg7d=+0.046 | Chg30d=+0.001 | Revisions Net=-2 | Analysts=17
EPS current Year (2026-12-31): EPS=1.96 | Chg7d=+0.387 | Chg30d=-0.182 | Revisions Net=-5 | Growth EPS=-47.9% | Growth Revenue=-20.6%
EPS next Year (2027-12-31): EPS=2.48 | Chg7d=+0.097 | Chg30d=+0.070 | Revisions Net=-2 | Growth EPS=+26.2% | Growth Revenue=+9.8%
[Analyst] Revisions Ratio: -0.33 (2 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.1% (Discount Rate 10.7% - Earnings Yield 12.8%)
[Growth] Growth Spread = -27.3% (Analyst -29.4% - Implied -2.1%)
P/E Forward = 14.7275
P/S = 1.3463
P/B = 1.9431
P/EG = 3.6802
Revenue TTM = 8.92b USD
EBIT TTM = 3.05b USD
EBITDA TTM = 5.46b USD
Long Term Debt = 4.28b USD (from longTermDebt, two quarters ago)
Short Term Debt = 310.0m USD (from shortTermDebt, last quarter)
Debt = 4.81b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.29b USD (from netDebt column, last quarter)
Enterprise Value = 15.99b USD (11.69b + Debt 4.81b - CCE 516.0m)
Interest Coverage Ratio = 11.52 (Ebit TTM 3.05b / Interest Expense TTM 265.0m)
EV/FCF = 8.99x (Enterprise Value 15.99b / FCF TTM 1.78b)
FCF Yield = 11.13% (FCF TTM 1.78b / Enterprise Value 15.99b)
FCF Margin = 19.94% (FCF TTM 1.78b / Revenue TTM 8.92b)
Net Margin = 16.08% (Net Income TTM 1.43b / Revenue TTM 8.92b)
Gross Margin = 38.09% ((Revenue TTM 8.92b - Cost of Revenue TTM 5.52b) / Revenue TTM)
Gross Margin QoQ = 39.23% (prev 38.68%)
Tobins Q-Ratio = 0.84 (Enterprise Value 15.99b / Total Assets 19.00b)
Interest Expense / Debt = 1.21% (Interest Expense 58.0m / Debt 4.81b)
Taxrate = 32.31% (158.0m / 489.0m)
NOPAT = 2.07b (EBIT 3.05b * (1 - 32.31%))
Current Ratio = 0.82 (Total Current Assets 2.12b / Total Current Liabilities 2.57b)
Debt / Equity = 0.79 (Debt 4.81b / totalStockholderEquity, last quarter 6.09b)
Debt / EBITDA = 0.79 (Net Debt 4.29b / EBITDA 5.46b)
Debt / FCF = 2.41 (Net Debt 4.29b / FCF TTM 1.78b)
Total Stockholder Equity = 5.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.47% (Net Income 1.43b / Total Assets 19.00b)
RoE = 24.51% (Net Income TTM 1.43b / Total Stockholder Equity 5.85b)
RoCE = 30.14% (EBIT 3.05b / Capital Employed (Equity 5.85b + L.T.Debt 4.28b))
RoIC = 19.54% (NOPAT 2.07b / Invested Capital 10.57b)
WACC = 7.83% (E(11.69b)/V(16.50b) * Re(10.71%) + D(4.81b)/V(16.50b) * Rd(1.21%) * (1-Tc(0.32)))
Discount Rate = 10.71% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 7.53%
[DCF] Terminal Value 75.30% ; FCFF base≈1.38b ; Y1≈1.11b ; Y5≈773.1m
[DCF] Fair Price = 29.38 (EV 14.71b - Net Debt 4.29b = Equity 10.42b / Shares 354.7m; r=7.83% [WACC]; 5y FCF grow -22.85% → 2.90% )
EPS Correlation: -78.36 | EPS CAGR: -18.05% | SUE: 0.86 | # QB: 1
Revenue Correlation: -34.40 | Revenue CAGR: -7.52% | SUE: -1.11 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.49 | Chg7d=+0.046 | Chg30d=+0.001 | Revisions Net=-2 | Analysts=17
EPS current Year (2026-12-31): EPS=1.96 | Chg7d=+0.387 | Chg30d=-0.182 | Revisions Net=-5 | Growth EPS=-47.9% | Growth Revenue=-20.6%
EPS next Year (2027-12-31): EPS=2.48 | Chg7d=+0.097 | Chg30d=+0.070 | Revisions Net=-2 | Growth EPS=+26.2% | Growth Revenue=+9.8%
[Analyst] Revisions Ratio: -0.33 (2 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.1% (Discount Rate 10.7% - Earnings Yield 12.8%)
[Growth] Growth Spread = -27.3% (Analyst -29.4% - Implied -2.1%)